Danaher Corporation (DHR) Stock Analysis & Winston Score

Danaher makes scientific tools and equipment used in hospitals, laboratories, and factories around the world. Its products help scientists run medical tests, develop new drugs, and filter water — covering areas like diagnostics, life sciences research, and water quality. The company owns well-known brands such as Beckman Coulter, Cytiva, and Hach, and sells primarily to hospitals, pharmaceutical companies, and research institutions. Danaher earns money by selling instruments upfront and then generating recurring revenue from the consumables, reagents, and software those instruments require — a model that keeps customers coming back. It operates globally, with significant revenue from North America, Europe, and Asia, and generates over $23 billion in annual sales. Its main competitive advantage is the "Danaher Business System," an internal operating framework focused on continuous improvement that has historically driven strong margins. The key risk is that life sciences spending by biotech and pharmaceutical companies has slowed since the post-pandemic boom, pressuring near-term revenue growth.